Keith A. Goldan

Chief Financial Officer, Syndax Pharmaceuticals Inc

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Jun 1, 2026

Companies

Syndax Pharmaceuticals IncChief Financial Officer −$0.1M

Trades

SNDX Sold 1,177 shares at $18.99 $0.0M Jun 1

SNDX Sold 3,410 shares at $21.03 $0.1M Feb 9

SNDX Sold 2,082 shares at $20.62 $0.0M Feb 6

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.